opioid epidemic
"The Illusion of Drugs" by Eyad Elbayoumi i

First Federal Trial Over Opioid Epidemic Begins Jury Selection Today

In the first federal trial over the opioid epidemic, two counties in Ohio, Summit and Cuyahoga, are suing generic drug makers Actavis and Cephalon; the distributors AmerisourceBergen, Cardinal Health and McKesson; and the pharmacy chain Walgreens.

Jury selection for the trial began Wednesday and trial arguments are scheduled to begin Monday. The trial is considered particularly important because it could likely shape how future claims against drug distributors and manufacturers are treated.

There are more than 2,000 lawsuits filed by local governments and other entities against drug companies for the opioid epidemic’s effects.

Around 68% of the more than 70,200 drug overdose deaths in 2017 involved an opioid. Also in 2017, the number of overdose deaths involving opioids, including prescriptions, heroin and illicitly manufactured fentanyl, was six times higher than in 1999, according to data from the Centers for Disease Control and Prevention.

Related Press: Boston’s Museum of Fine Arts Addresses Racism with Multiple Projects

Summit and Cuyahoga counties are claiming in the suit that the named drug companies, and others, distributed and sold prescription painkillers in a conspiracy that has cost the counties hundreds of millions of dollars a year as well as lives of citizens who have died from overdoses.

Some companies have escaped a trial by reaching a settlement or declaring bankruptcy. Purdue Pharma is one of five companies that has done that in order to be dismissed from its first federal trial.

It could take up to three days to choose jurors for the trial because of recent complications where a potential settlement was reported in the Wall Street Journal. People from Summit County won’t be on the jury and anyone who says they have a close connection to the opioid crisis, such as losing a loved one, will not be part of the jury.

The drug companies say they’re not at fault because they only supplied drugs that doctors prescribed.

Latest News

What Friends Tell Friends: Choose Kaiser Permanente

Originally published on about.kaiserpermanente.org. Integrated, nonprofit health plan tops NICE Satmetrix customer experience benchmark study for 10th straight year. For the 10th year in a row, more people would recommend Kaiser Permanente to a friend or colleague than any other health plan in the nation, according to the recently released…

Cesar Conde

NBCUniversal Sets Ambitious 50% Diversity Goal for Women, People of Color

Cesar Conde, chairman at NBCUniversal News Group, announced a groundbreaking goal to have a 50% diverse workforce at NBCUniversal, according to Deadline. Conde, the first Latino in this role, outlined his plans in an internal video for employees on Wednesday. The ultimate goal is for NBCUniversal, No. 7 on DiversityInc’s 2020…

Mastercard Expands ShopOpenings.com to the U.S. & Canada, Delivering a Search Tool That Identifies What Stores Near You Are Open for Business

Originally published on mastercardcontentexchange.com. Search solution complements new Digital Acceleration for Small Business global initiative which helps small businesses advance digitally and drive online commerce As businesses seek to draw customers back both in store and online, Mastercard is introducing new tools to support them. Today, Mastercard announced the geographic…

TIAA Launches Programs to Raise Awareness of Racial Injustice and Support Communities in Need through the “Be The Change” Initiative

On June 30, TIAA announced new virtual programs designed to raise awareness of racial injustice and support communities in need as a part of the company’s recently launched “Be the Change” initiative. One is TIAA’s “Race Against Racism,” an effort in support of The Innocence Project which included more than…

Stop TB Partnership and Johnson & Johnson, with support from USAID and The Global Fund, Announce Price Reduction for SIRTURO® (bedaquiline) for Treatment of Drug-Resistant Tuberculosis in Low- and Middle-Income Countries

Originally published on jnj.com. Joint efforts aim to accelerate scale-up of WHO-recommended all-oral treatment regimens – a transition urgently needed to help protect the health of people with drug resistant-tuberculosis who are particularly vulnerable during COVID-19 pandemic In 2020, the initiative aims to reach at least 125,000 patients and could…

Toyota, Alabama A&M and Huntsville Hospital Collaborate to Make COVID-19 Testing Easier

Originally published on pressroom.toyota.com. $100,000 grant provides free service to the community Alabama A & M University (AAMU), Huntsville Hospital and Toyota are developing a mobile health clinic initiative to provide free COVID-19 testing to underserved communities in Madison County. Launching later this year, the mobile medical clinic program has…

Sanofi and Regeneron Provide Update on Kevzara® (sarilumab) Phase 3 U.S. Trial in COVID-19 Patients

Originally published on sanofi.com. Sanofi and Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that the U.S. Phase 3 trial of Kevzara® (sarilumab) 400 mg in COVID-19 patients requiring mechanical ventilation did not meet its primary and key secondary endpoints when Kevzara was added to best supportive care compared to best supportive care alone (placebo)….